Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Namløs, Heidi M ^a   Kresse, Stine H ^a   Müller, Christoph R ^a,b   Henriksen, Jørn ^a   Holdhus, Rita ^c   Sæter, Gunnar ^a   Bruland, Øyvind S ^a   Bjerkehagen, Bodil ^a   Steen, Vidar M ^c,d   Myklebost, Ola ^a,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Sorlandet Hospital Kristiansand   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; COMPLEMENT COMPONENT C1Q; FILENSIN; IROQUOIS HOMEOBOX PROTEIN 2; LEUKOCYTE RECEPTOR CLUSTER MEMBER 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 15; NEUROLIGIN; NEUROLIGIN 4; PRKAR2B PROTEIN; PROTEASE SERINE 27; PROTEIN; RAPGEF4 PROTEIN; RGS4 PROTEIN; RHO GUANINE EXCHANGE FACTOR 16; TRANSMEMBRANE PROTEIN 37; TUMOR NECROSIS FACTOR RELATED PROTEIN 7; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 396;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MICROARRAY ANALYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; SCHOOL CHILD; SIGNAL TRANSDUCTION;

EID: 84858116745     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/639038     Document Type: Article

References (46)

1. Mirabello L., Troisi R. J., Savage S. A., Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program Cancer 2009 115 7 1531 1543
2. Raymond A. K., Ayala A. G., Knuutila S., Fletcher C. D. M., Unni K. K., Mertens F., Conventional osteosarcoma World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 Lyon, France IARC Press
3. Hattinger C. M., Pasello M., Ferrari S., Picci P., Serra M., Emerging drugs for high-grade osteosarcoma Expert Opinion on Emerging Drugs 2010 15 4 615 634
4. PosthumaDeBoer J., Witlox M. A., Kaspers G. J., van Royen B. J., Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature Clinical and Experimental Metastasis 2011 28 5 493 503
5. Aksnes L. H., Hall K. S., Folleraas G., Stenwig A. E., Bjerkehagen B., Taksdal I., Winderen M., Bruland. S., Ster G., Management of high-grade bone sarcomas over two decades: the Norwegian Radium Hospital experience Acta Oncologica 2006 45 1 38 46 (Pubitemid 43214640)
6. Bielack S. S., Kempf-Bielack B., Delling G., Exner G. U., Flege S., Helmke K., Kotz R., Salzer-Kuntschik M., Wemer M., Winkelmann W., Zoubek A., Jrgens H., Winkler K., Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols Journal of Clinical Oncology 2002 20 3 776 790 (Pubitemid 34111386)
7. Bacci G., Briccoli A., Rocca M., Ferrari S., Donati D., Longhi A., Bertoni F., Bacchini P., Giacomini S., Forni C., Manfrini M., Galletti S., Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide Annals of Oncology 2003 14 7 1126 1134 (Pubitemid 36950179)
8. Kager L., Zoubek A., Ptschger U., Kastner U., Flege S., Kempf-Bielack B., Branscheid D., Kotz R., Salzer-Kuntschik M., Winkelmann W., Jundt G., Kabisch H., Reichardt P., Jrgens H., Gadner H., Bielack S. S., Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols Journal of Clinical Oncology 2003 21 10 2011 2018 (Pubitemid 46606391)
9. Bakhshi S., Radhakrishnan V., Prognostic markers in osteosarcoma Expert Review of Anticancer Therapy 2010 10 2 271 287
10. Broadhead M. L., Clark J. C., Myers D. E., Dass C. R., Choong P. F., The molecular pathogenesis of osteosarcoma: a review Sarcoma 2011 2011 959248
11. Zucchini C., Rocchi A., Manara M. C., De Sanctis P., Capanni C., Bianchini M., Carinci P., Scotlandi K., Valvassori L., Apoptotic genes as potential markers of metastatic phenotype in human osteosarcoma cell lines International Journal of Oncology 2008 32 1 17 31 (Pubitemid 351176058)
12. Nakano T., Tani M., Ishibashi Y., Kimura K., Park Y. B., Imaizumi N., Tsuda H., Aoyagi K., Sasaki H., Ohwada S., Yokota J., Biological properties and gene expression associated with metastatic potential of human osteosarcoma Clinical and Experimental Metastasis 2003 20 7 665 674 (Pubitemid 37463904)
13. Chen X., Yang T. T., Qiu X. C., Gene expression profiles of human osteosarcoma cell sublines with different pulmonary metastatic potentials Cancer Biology Therapy 2011 11 2 287 292
14. Buddingh E. P., Kuijjer M. L., Duim R. A., Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents Clinical Cancer Research 2011 17 8 2110 2119
15. Saal L. H., Troein C., Vallon-Christersson J., Gruvberger S., Borg A., Peterson C., BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data Genome Biology 2002 3 8
16. Gentleman R. C., Carey V. J., Bates D. M., Bolstad B., Dettling M., Dudoit S., Ellis B., Gautier L., Ge Y., Gentry J., Hornik K., Hothorn T., Huber W., Iacus S., Irizarry R., Leisch F., Li C., Maechler M., Rossini A. J., Sawitzki G., Smith C., Smyth G., Tierney L., Yang J. Y., Zhang J., Bioconductor: open software development for computational biology and bioinformatics Genome Biology 2004 5 10
17. Thomas P. D., Campbell M. J., Kejariwal A., Mi H., Karlak B., Daverman R., Diemer K., Muruganujan A., Narechania A., PANTHER: a library of protein families and subfamilies indexed by function Genome Research 2003 13 9 2129 2141 (Pubitemid 37161770)
18. Thomas P. D., Kejariwal A., Guo N., Mi H., Campbell M. J., Muruganujan A., Lazareva-Ulitsky B., Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools Nucleic Acids Research 2006 34 W645 W650
19. Dysvik B., Jonassen I., J-Express: exploring gene expression data using Java Bioinformatics 2001 17 4 369 370 (Pubitemid 32421932)
20. Tusher V. G., Tibshirani R., Chu G., Significance analysis of microarrays applied to the ionizing radiation response Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5116 5121 (Pubitemid 32397092)
21. Mller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verstegui E., Zlotnik A., Involvement of chemokine receptors in breast cancer metastasis Nature 2001 410 6824 50 56 (Pubitemid 32225831)
22. Singh R., Lillard J. W. Jr., Singh S., Chemokines: key players in cancer progression and metastasis Frontiers in Bioscience (Scholar Edition) 2011 3 1569 1582
23. Bennani-Baiti I. M., Cooper A., Lawlor E. R., Kauer M., Ban J., Aryee D. N. T., Kovar H., Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma Clinical Cancer Research 2010 16 14 3769 3778
24. Laverdiere C., Hoang B. H., Yang R., Sowers R., Qin J., Meyers P. A., Huvos A. G., Healey J. H., Gorlick R., Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma Clinical Cancer Research 2005 11 7 2561 2567 (Pubitemid 40569454)
25. Dunn D., Dehner L. P., Metastatic osteosarcoma to lung: a clinicopathologic study of surgical biopsies and resections Cancer 1977 40 6 3054 3064
26. Krishnamoorthy N., Desai S. S., Rekhi B., Jambhekar N. A., A clinico-morphological study of 95 cases of sarcomas with metastases to the lungs Indian Journal Cancer 2011 48 3 335 338
27. Biche I., Chavey C., Andrieu C., Busson M., Vacher S., Le Corre L., Guinebretire J. M., Burlinchon S., Lidereau R., Lazennec G., CXC chemokines located in the 4q21 region are up-regulated in breast cancer Endocrine-Related Cancer 2007 14 4 1039 1052 (Pubitemid 351252435)
28. Batanian J. R., Cavalli L. R., Aldosari N. M., Ma E., Sotelo-Avila C., Ramos M. B., Rone J. D., Thorpe C. M., Haddad B. R., Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses Journal of Clinical PathologyMolecular Pathology 2002 55 6 389 393 (Pubitemid 35454514)
29. Lau C. C., Harris C. P., Lu X. Y., Perlaky L., Gogineni S., Chintagumpala M., Hicks J., Johnson M. E., Davino N. A., Huvos A. G., Meyers P. A., Healy J. H., Gorlick R., Rao P. H., Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma Genes Chromosomes and Cancer 2004 39 1 11 21 (Pubitemid 37475248)
30. Brounais B., Chipoy C., Mori K., Charrier C., Battaglia S., Pilet P., Richards C. D., Heymann D., Rédini F., Blanchard F., Oncostatin M induces bone loss and sensitizes rat osteosarcoma to the antitumor effect of midostaurin in vivo Clinical Cancer Research 2008 14 17 5400 5409
31. David E., Guihard P., Brounais B., Direct anti-cancer effect of oncostatin M on chondrosarcoma International Journal of Cancer 2011 128 8 1822 1835
32. Brounais B., David E., Chipoy C., Trichet V., Ferré V., Charrier C., Duplomb L., Berreur M., Rédini F., Heymann D., Blanchard F., Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells Bone 2009 44 5 830 839
33. Fossey S. L., Bear M. D., Kisseberth W. C., Pennell M., London C. A., Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines BMC Cancer 2011 11, article 125
34. Jorcyk C. L., Holzer R. G., Ryan R. E., Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells Cytokine 2006 33 6 323 336 (Pubitemid 43948887)
35. Argast G. M., Mercado P., Mulford I. J., O'Connor M., Keane D. M., Shaaban S., Epstein D. M., Pachter J. A., Kan J. L. C., Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor- enhances epithelial to mesenchymal transition in lung and pancreatic tumor models Cells Tissues Organs 2011 193 1-2 114 132
36. Holzer R. G., Ryan R. E., Tommack M., Schlekeway E., Jorcyk C. L., Oncostatin M stimulates the detachment of a reservoir of invasive mammary carcinoma cells: role of cyclooxygenase-2 Clinical and Experimental Metastasis 2004 21 2 167 176 (Pubitemid 38988090)
37. Betz C., Papadopoulos T., Buchwald J., Dammrich J., Muller-Hermelink H. K., Surfactant protein gene expression in metastatic and micrometastatic pulmonary adenocarcinomas and other non-small cell lung carcinomas: detection by reverse transcriptase-polymerase chain reaction Cancer Research 1995 55 19 4283 4286
38. Balkwill F., The significance of cancer cell expression of the chemokine receptor CXCR4 Seminars in Cancer Biology 2004 14 3 171 179 (Pubitemid 38586742)
39. Perissinotto E., Cavalloni G., Leone F., Fonsato V., Mitola S., Grignani G., Surrenti N., Sangiolo D., Bussolino F., Piacibello W., Aglietta M., Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression Clinical Cancer Research 2005 11 2, part 1 490 497 (Pubitemid 40116871)
40. Oda Y., Yamamoto H., Tamiya S., Matsuda S., Tanaka K., Yokoyama R., Iwamoto Y., Tsuneyoshi M., CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis Modern Pathology 2006 19 5 738 745
41. Fan T. M., Barger A. M., Fredrickson R. L., Fitzsimmons D., Garrett L. D., Investigating CXCR4 expression in canine appendicular osteosarcoma Journal of Veterinary Internal Medicine 2008 22 3 602 608
42. Bai S., Wang D., Klein M. J., Siegal G. P., Characterization of CXCR4 expression in chondrosarcoma of bone Archives of Pathology Laboratory Medicine 2011 135 6 753 758
43. Théoleyre S., Mori K., Cherrier B., Passuti N., Gouin F., Rédini F., Heymann D., Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma BMC Cancer 2005 5, article 123
44. von Luettichau I., Segerer S., Wechselberger A., Notohamiprodjo M., Nathrath M., Kremer M., Henger A., Djafarzadeh R., Burdach S., Huss R., Nelson P. J., A complex pattern of chemokine receptor expression is seen in osteosarcoma BMC Cancer 2008 8, article 23
45. Kim S. Y., Lee C. H., Midura B. V., Yeung C., Mendoza A., Hong S. H., Ren L., Wong D., Korz W., Merzouk A., Salari H., Zhang H., Hwang S. T., Khanna C., Helman L. J., Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases Clinical and Experimental Metastasis 2008 25 3 201 211
46. Liang Z., Wu H., Reddy S., Zhu A., Wang S., Blevins D., Yoon Y., Zhang Y., Shim H., Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA Biochemical and Biophysical Research Communications 2007 363 3 542 546 (Pubitemid 47513664)